• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Article

July 21, 2016

Trending News Today: Cancer Diagnosis Reporting in Real-Time

Author(s):

Lauren Santye, Assistant Editor

Top news of the day from across the health care landscape.

For the first time, pathologists at a dozen hospitals in California are reporting cancer diagnoses in close to real-time to the California Cancer Registry as part of a pilot project, reported Kaiser Health News. Current registries primarily used for research and surveillance of cancer trends based on historic data tend to lack consistency and timeliness. The California registry has been collecting information on cancer patients since 1988, and has accrued data on more than 4.5 million patients. Traditionally, the registry relies on data up to 2-years-old, but the new pilot project uses standardized electronic forms to make reporting more accurate and consistent, which could make a significant change to this practice.

A recent study revealed that since January 2015, Senior Health Partners, and at least 2 others, have been systematically cutting home care hours for disabled clients. According to The New York Times, this practice typically occurs without legal justification or proper notice and, by law, only a change in a client’s medical condition or circumstance is supposed to allow a reduction. The study was sponsored by Medicaid Matters and the New York chapter of the National Academy of Elder Law Attorneys. Furthermore, it confirmed similar allegations made in a federal class-action lawsuit filed earlier this year against Senior Health Partners and the New York State Health Department. The lawsuit was on behalf of elderly and disabled clients who were threatened with home care cuts.

The FDA approved the generic versions of the cholesterol lowering drug Crestor, reported The New York Times. Although AstraZeneca attempted to stop cheaper competition from reaching the pharmacy shelves, this new approval will significantly decrease the cost of Crestor and result in a sharp loss of market share for AstraZeneca. Currently, the brand name drug costs about $260 a month, according to GoodRx.com, but with several generics coming onto the market, the price may eventually drop by as much as 80 to 90%.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Related Content
Advertisement
Acalabrutinib capsules | Image Credit: © luchschenF - stock.adobe.com
August 15th 2025

Acalabrutinib Demonstrates Improved Safety, Survival to Chemoimmunotherapy in CLL

Alexandra Gerlach, Associate Editor
Pharmacy Times, Pharmacy Focus Oncology Edition
August 15th 2025

Taletrectinib Takes Aim: A New Chapter in ROS1-Positive NSCLC

Alexandra Gerlach, Associate Editor Kevin Chen, PharmD Amanda Cass, PharmD, BCPS, BCOP
Pharmacist drawing vaccine from vial | Image Credit: © Alernon77 - stock.adobe.com
August 15th 2025

KRAS-Targeted Vaccine Shows Durable Immune Responses, Survival Benefits in Pancreatic Colorectal Cancers

Alexandra Gerlach, Associate Editor
Pharmacy Times, Pharmacy Focus Oncology Edition
August 15th 2025

Allen's Story: The Promising Potential of Intratumoral Immunotherapy

Alexandra Gerlach, Associate Editor
Lung adenocarcinoma -- Image credit: MdBabul | stock.adobe.com
August 15th 2025

High Perilipin 2 Expression Associated With Disease Progression, Shorter Survival in Lung Adenocarcinoma

Gillian McGovern, Associate Editor
Bleeding stroke brain artery, Cellular structure with intricate connections and a vibrant red nucleus, representing biological elements.
August 15th 2025

Atorvastatin Improves Outcomes, LDL-C Following Pipeline Therapy for Intracranial Aneurysms

Luke Halpern, Assistant Editor
Related Content
Advertisement
Acalabrutinib capsules | Image Credit: © luchschenF - stock.adobe.com
August 15th 2025

Acalabrutinib Demonstrates Improved Safety, Survival to Chemoimmunotherapy in CLL

Alexandra Gerlach, Associate Editor
Pharmacy Times, Pharmacy Focus Oncology Edition
August 15th 2025

Taletrectinib Takes Aim: A New Chapter in ROS1-Positive NSCLC

Alexandra Gerlach, Associate Editor Kevin Chen, PharmD Amanda Cass, PharmD, BCPS, BCOP
Pharmacist drawing vaccine from vial | Image Credit: © Alernon77 - stock.adobe.com
August 15th 2025

KRAS-Targeted Vaccine Shows Durable Immune Responses, Survival Benefits in Pancreatic Colorectal Cancers

Alexandra Gerlach, Associate Editor
Pharmacy Times, Pharmacy Focus Oncology Edition
August 15th 2025

Allen's Story: The Promising Potential of Intratumoral Immunotherapy

Alexandra Gerlach, Associate Editor
Lung adenocarcinoma -- Image credit: MdBabul | stock.adobe.com
August 15th 2025

High Perilipin 2 Expression Associated With Disease Progression, Shorter Survival in Lung Adenocarcinoma

Gillian McGovern, Associate Editor
Bleeding stroke brain artery, Cellular structure with intricate connections and a vibrant red nucleus, representing biological elements.
August 15th 2025

Atorvastatin Improves Outcomes, LDL-C Following Pipeline Therapy for Intracranial Aneurysms

Luke Halpern, Assistant Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.